|
JPS5822474B2
(ja)
*
|
1980-06-10 |
1983-05-09 |
天野製薬株式会社 |
コレシストキニン・パンクレオザイミンｃ端ペプチドアミドスルフエ−トエステルの製造法
|
|
US4427660A
(en)
*
|
1982-03-03 |
1984-01-24 |
Research Corporation |
Formyl-methionyl chemotatic peptide antibiotic conjugates useful in treating infections
|
|
US4571336A
(en)
*
|
1983-08-25 |
1986-02-18 |
Endorphin, Inc. |
Immune stimulation
|
|
US4977244A
(en)
*
|
1985-06-27 |
1990-12-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Uromodulin and a process of purifying it
|
|
US4855285A
(en)
*
|
1985-12-04 |
1989-08-08 |
The Ohio State University Research Foundation |
Antigenic modification of polypeptides
|
|
US4753965A
(en)
*
|
1987-04-09 |
1988-06-28 |
Merrell Dow Pharmaceuticals, Inc. |
Method of treating multiple sclerosis with chalcone derivatives
|
|
US5002961A
(en)
*
|
1987-10-19 |
1991-03-26 |
Merrell Dow Pharmaceuticals |
Method for reducing injury with imidazol-2-thionecarboxamides
|
|
DE68926178T2
(de)
*
|
1988-05-10 |
1996-11-28 |
Alpha 1 Biomedicals Inc |
Festphase-Verfahren zur Gewinnung von Thymosin-alpha-1
|
|
US5055447A
(en)
*
|
1988-07-28 |
1991-10-08 |
Genentech, Inc. |
Method and compositions for the treatment and prevention of septic shock
|
|
US6051596A
(en)
*
|
1990-08-10 |
2000-04-18 |
Anormed, Inc. |
Immunosuppressive compositions
|
|
US5958413A
(en)
*
|
1990-11-01 |
1999-09-28 |
Celltech Limited |
Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor
|
|
US5223397A
(en)
*
|
1991-06-05 |
1993-06-29 |
Sangstat Medical Corporation |
Soluble hla cross-match
|
|
DE4138621A1
(de)
*
|
1991-11-25 |
1993-06-17 |
Boehringer Ingelheim Int |
Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabhaengigen zellulaeren signaluebertragungsweg
|
|
DE69333433T2
(de)
*
|
1992-04-01 |
2004-12-02 |
The Rockefeller University |
Verfahren zur in vitro kultivierung dendritischer vorläuferzellen und deren verwendung zur immunogen herstellung
|
|
US5273961A
(en)
*
|
1992-09-22 |
1993-12-28 |
Genentech, Inc. |
Method of prophylaxis of acute renal failure
|
|
US5380668A
(en)
*
|
1993-07-06 |
1995-01-10 |
University Of Utah Research Foundation |
Compounds having the antigenicity of hCG
|
|
NZ278607A
(en)
*
|
1994-02-07 |
1999-05-28 |
Knoll Ag |
Use of tnf antagonists for treating disorders involving elevated serum levels of il-6 wherein the serum levels are 500pg/ml or above
|
|
US5677275A
(en)
*
|
1994-08-05 |
1997-10-14 |
The United States Of America As Represented By The Department Of Health And Human Services |
Treatment of cancer with human chorionic gonadotropin
|
|
US5851997A
(en)
*
|
1994-10-04 |
1998-12-22 |
Harris; Pamela Jo |
Use of human chorionic gonadotropin as an immune-potentiating antiviral agent
|
|
SE520730C2
(sv)
*
|
1995-01-20 |
2003-08-19 |
Eskil Elmer |
Behandling av hjärnischemi och hjärnskador med ett neuroprotektivt läkemedel
|
|
WO1996032412A1
(en)
*
|
1995-04-13 |
1996-10-17 |
Chugai Seiyaku Kabushiki Kaisha |
PEPTIDE SUPPRESSING IxBα PHOSPHORYLATION
|
|
US5942494A
(en)
*
|
1995-10-06 |
1999-08-24 |
The Trustees Of Columbia University In The City Of New York |
Stimulation of gene expression and synthesis of heat shock protein 72/73 (HSP 70)
|
|
US6361992B1
(en)
*
|
1996-05-08 |
2002-03-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Thyroid stimulating hormone superagonists
|
|
US5997871A
(en)
*
|
1996-06-24 |
1999-12-07 |
University Of Maryland Biotechnology Insitute |
Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
|
|
US5968513A
(en)
*
|
1996-06-24 |
1999-10-19 |
University Of Maryland Biotechnology Institute |
Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
|
|
US6319504B1
(en)
*
|
1996-06-24 |
2001-11-20 |
University Of Maryland Biotechnology Institute |
Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
|
|
US6150500A
(en)
*
|
1996-07-12 |
2000-11-21 |
Salerno; John C. |
Activators of endothelial nitric oxide synthase
|
|
GB9624927D0
(en)
*
|
1996-11-29 |
1997-01-15 |
Oxford Glycosciences Uk Ltd |
Gels and their use
|
|
US5966712A
(en)
*
|
1996-12-12 |
1999-10-12 |
Incyte Pharmaceuticals, Inc. |
Database and system for storing, comparing and displaying genomic information
|
|
US6416959B1
(en)
*
|
1997-02-27 |
2002-07-09 |
Kenneth Giuliano |
System for cell-based screening
|
|
US5801193A
(en)
*
|
1997-04-15 |
1998-09-01 |
Immune Modulation, Inc. |
Compositions and methods for immunosuppressing
|
|
US6583109B1
(en)
*
|
1997-06-24 |
2003-06-24 |
Robert C. Gallo |
Therapeutic polypeptides from β-hCG and derivatives
|
|
HUP0001237A3
(en)
*
|
1997-10-20 |
2002-01-28 |
Lilly Co Eli |
Methods for treating vascular disorders
|
|
US6831057B2
(en)
*
|
1997-10-28 |
2004-12-14 |
The University Of North Carolina At Chapel Hill |
Use of NF-κB inhibition in combination therapy for cancer
|
|
US6075150A
(en)
*
|
1998-01-26 |
2000-06-13 |
Cv Therapeutics, Inc. |
α-ketoamide inhibitors of 20S proteasome
|
|
US7175679B2
(en)
*
|
2001-03-29 |
2007-02-13 |
Biotempt B.V. |
Oligopeptide treatment of NF-κB mediated inflammation
|
|
US6921751B1
(en)
*
|
1998-05-20 |
2005-07-26 |
Erasmus Universiteit Rotterdam |
Immunoregulator
|
|
US6844315B2
(en)
*
|
1998-05-20 |
2005-01-18 |
Erasmus Universiteit Rotterdam |
Immunoregulator
|
|
EP1138692A1
(en)
*
|
2000-03-29 |
2001-10-04 |
Erasmus Universiteit Rotterdam |
Fragments of human chorionic gonadotropin (hcg) as immunoregulator
|
|
US20030220258A1
(en)
*
|
2001-12-21 |
2003-11-27 |
Robbert Benner |
Treatment of ischemic events
|
|
US20050227925A1
(en)
*
|
2004-04-08 |
2005-10-13 |
Robbert Benner |
Compositions capable of reducing elevated blood urea concentration
|
|
AU1254700A
(en)
*
|
1998-11-20 |
2000-06-13 |
Mount Sinai Hospital Corporation |
Peptides that modulate the interaction of b class ephrins and pdz domains
|
|
US6507788B1
(en)
*
|
1999-02-25 |
2003-01-14 |
Société de Conseils de Recherches et D'Applications Scientifiques (S.C.R.A.S.) |
Rational selection of putative peptides from identified nucleotide, or peptide sequences, of unknown function
|
|
CA2366678A1
(en)
*
|
1999-03-09 |
2000-09-14 |
Fornix Biosciences N.V. |
Synthetic complementary peptides and ophthalmologic uses thereof
|
|
US20030148955A1
(en)
*
|
1999-04-19 |
2003-08-07 |
Pluenneke John D. |
Soluble tumor necrosis factor receptor treatment of medical disorders
|
|
US6379970B1
(en)
*
|
1999-04-30 |
2002-04-30 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Analysis of differential protein expression
|
|
RU2157233C1
(ru)
*
|
1999-05-11 |
2000-10-10 |
Санкт-Петербургская общественная организация "Институт биорегуляции и геронтологии" |
Тетрапептид, обладающий геропротекторной активностью, фармакологическое средство на его основе и способ его применения
|
|
CA2400187A1
(en)
*
|
2000-02-11 |
2001-08-16 |
Eli Lilly And Company |
Protein c derivatives
|
|
WO2001068113A1
(en)
*
|
2000-03-10 |
2001-09-20 |
Monsanto Technology Llc |
Anti-hypertensive peptides
|
|
EP1300418A1
(en)
*
|
2001-10-04 |
2003-04-09 |
Erasmus Universiteit Rotterdam |
Gene regulation by oligopeptides
|
|
US7358330B2
(en)
*
|
2001-03-29 |
2008-04-15 |
Biotempt B.V. |
Immunoregulatory compositions
|
|
US20050037430A1
(en)
*
|
2000-03-29 |
2005-02-17 |
Biotempt B.V. |
Methods and uses for protein breakdown products
|
|
US6783757B2
(en)
*
|
2000-06-01 |
2004-08-31 |
Kirkman Group, Inc. |
Composition and method for increasing exorphin catabolism to treat autism
|
|
US6539102B1
(en)
*
|
2000-09-01 |
2003-03-25 |
Large Scale Proteomics |
Reference database
|
|
EP1217540A1
(en)
*
|
2000-11-29 |
2002-06-26 |
Lafayette Software Inc. |
Methods of organizing data and processing queries in a database system, and database system and software product for implementing such method
|
|
CA2448668A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Trillium Therapeutics Inc. |
Modulation of cd200 receptors
|
|
US20030220259A1
(en)
*
|
2001-12-21 |
2003-11-27 |
Robbert Benner |
Treatment of neurological disorders
|
|
US20030220260A1
(en)
*
|
2001-12-21 |
2003-11-27 |
Khan Nisar Ahmed |
Peptide compositions
|
|
US20030220257A1
(en)
*
|
2001-12-21 |
2003-11-27 |
Robbert Benner |
Treatment of trauma
|
|
US20040013661A1
(en)
*
|
2001-12-21 |
2004-01-22 |
Gert Wensvoort |
Stratification
|
|
US7501391B2
(en)
*
|
2001-12-21 |
2009-03-10 |
Biotempt B.V. |
Treatment of transplant survival
|
|
US7560433B2
(en)
*
|
2001-12-21 |
2009-07-14 |
Biotempt B.V. |
Treatment of multiple sclerosis (MS)
|
|
US20030224995A1
(en)
*
|
2001-12-21 |
2003-12-04 |
Khan Nisar Ahmed |
Treatment of burns
|
|
US20030220261A1
(en)
*
|
2001-12-21 |
2003-11-27 |
Khan Nisar Ahmed |
Treatment of iatrogenic disease
|
|
US7135286B2
(en)
*
|
2002-03-26 |
2006-11-14 |
Perlegen Sciences, Inc. |
Pharmaceutical and diagnostic business systems and methods
|
|
US7517529B2
(en)
*
|
2003-04-08 |
2009-04-14 |
Biotempt B.V. |
Treatment of type I diabetes
|